Elvia Adriana Morales Hipólito

Prof. Elvia Adriana Morales Hipólito


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
XMXimena Hernández Martínez
Ximena Hernández Martínez
CCCarla O. Contreras-Ochoa
Carla O. Contreras-Ochoa
MMMarisol Mir-Garcia
Marisol Mir-Garcia
YAYessica Nataly Aguilar-García
Yessica Nataly Aguilar-García
HMHugo Cortés Martínez
Hugo Cortés Martínez
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
The objective of the present study was to develop injectable solutions of curcumin (CUR) and resveratrol (RES) for intravenous administration as a strategy to increase their solubility and stability, as well as to evaluate their cytotoxic potential, individually and in combination, on human lung non-small adenocarcinoma cells (A549 cells) and non-tumoral cells isolated from normal human bronchial epithelium (BEAS cells) to establish possible synergistic effects and potential therapeutic alternatives for lung cancer. Using factorial experimental designs, the components of the injectable CUR and RES solutions were selected, and their hemolytic potential was evaluated by a static method. In addition, combinations of injectable CUR:RES solutions (25:75, 50:50 and 75:25) were prepared from the individual ones, and their stability under refrigeration conditions and cytotoxic potential on A549 and BEAS cells were evaluated. The stability of the injectable solutions of CUR, RES and their different combinations was maintained for 3 months, except for the 25:75 combination of CUR:RES. Furthermore, the cytotoxic potential of CUR and RES on tumoral cells (A549) and non-tumoral (BEAS) cells was evaluated, indicating a dose-dependent effect; the combination of CUR:RES 50:50 and the combination of CUR:RES 75:25 presented synergistic effects in reducing cell viability. This study suggests that injectable solutions of CUR, RES and their combination for intravenous administration could be potential viable candidates and should be evaluated for their efficacy in animal models of lung cancer to establish new possible treatments.

30 March 2026 in Foods
Verified
Journal Article
Open access
PDF file
KGKarla S. Garcia-Salazar
Karla S. Garcia-Salazar
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
JGJesus Adonai Maguey Gonzalez
Jesus Adonai Maguey Gonzalez
JLJuan Latorre
Juan Latorre
EHElvia Adriana Morales Hipólito
Elvia Adriana Morales Hipólito
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
The use of agro-industrial waste to obtain biochar has emerged as an environmentally friendly, low-cost, effective, profitable, and sustainable strategy for the removal of aflatoxin B1 (AFB1), a highly toxic and carcinogenic mycotoxin of importance in poultry production systems because it can cause serious economic losses, affect hatchability, egg production, and the growth of birds, and can cause their death. In this sense, the objective of the present study was to obtain a sustainable and low-cost biochar derived from agro-industrial coconut shell waste (BCS) and evaluate its AFB1 adsorption capacity using a conventional method based on buffer solutions and an in vitro avian digestion model that simulates the conditions of the gastrointestinal tract of the broiler chicken. The results showed that the adsorption capacity of BCS on AFB1 (250 ng/mL) at both pH 5.0 and 1.2 was close to 100%, while at pH 6.8, the adsorption of AFB1 was 86.24%. However, in the in vitro avian digestibility model, the adsorption capacity of BSC on AFB1 was 32.96%, thus highlighting the importance of considering factors that can affect the adsorption capacity of materials before in vivo studies, as this can lead to overestimations of results and, therefore, ineffective treatments or unexpected results in animals.

27 June 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KGKarla S. Garcia-Salazar
Karla S. Garcia-Salazar
HLHector J. Leon-Solano
Hector J. Leon-Solano
JGJesus Adonai Maguey Gonzalez
Jesus Adonai Maguey Gonzalez
JLJuan Latorre
Juan Latorre
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
Background/Objectives: Salmonella Infantis (S. Infantis) is a bacterium that has gained importance in public health over the last decade due to its high pathogenicity and resistance to antibiotics. Therefore, the objective of the present study was to present key considerations for the design and development of geraniol-loaded nanocapsules for its delivery in the drinking water or feed of broiler chickens and to evaluate its potential as an antimicrobial agent against S. Infantis using a standard in vitro microplate assay and a model that simulates the pH and feed conditions of the crop of broiler chickens. Methods: Using a 3k factorial experimental design, geraniol nanocapsule-based formulations were selected, and their antimicrobial activity was evaluated in in vitro models. Results: The results demonstrated that geraniol alone exhibits antimicrobial action against S. Infantis mainly due to its lipophilicity, hydrophobicity and the presence of the hydroxyl group found in its chemical structure, but when formulated in nanocapsular systems, the interaction of its components tends to reduce its antimicrobial action, especially the mixture of Tween 80:Span 80 and Miglyol® 810N. Furthermore, the use of the in vitro model that simulates the crop of broiler chickens demonstrated that the formulation also has interactions with the feed components, completely nullifying the antimicrobial action of geraniol compared to that obtained in the in vitro microplate model. Conclusions: Preformulation studies during the development of nanocapsule-based formulations should be considered for the correct selection of the components of a formulation to ensure its effectiveness, without only considering the physicochemical and stability properties of these as is frequently seen in studies.

29 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SHSandra Hernández-Ojeda
Sandra Hernández-Ojeda
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
CCCarla O. Contreras-Ochoa
Carla O. Contreras-Ochoa
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
RCRafael Camacho-Carranza
Rafael Camacho-Carranza
JEJavier Jesús Espinosa-Aguirre
Javier Jesús Espinosa-Aguirre
Background/Objectives: Although several studies have been reported on the modulation of Cytochrome P450 by resveratrol, inconsistencies in the results obtained require further investigation. Here, we report the results of in vivo and in vitro experiments investigating the effect of resveratrol on CYP1A2, which participates in the biotransformation of several drugs used for the treatment of human malignancies. Methods: Male Wistar rats were exposed to resveratrol through diet (1%) for 30 days, and the hepatic CYP1A2 activity and protein concentration were assayed at the end of the treatment. Additionally, the capacity of the phytochemical to interfere with the induction of CYP1A2 by benzo[a]pyrene (50 mg/kg body weight) was also studied. The inhibition of CYP1A2 activity in rat liver microsomal and recombinant human enzymes by resveratrol, as well as its inhibitory kinetics and type of inhibition, were compared. Results: No significant increase in the protein concentration of hepatic CYP1A2 was found in resveratrol-treated rats, but it induces CYP1A2 activity and enhances the induction effect of benzo[a]pyrene. In silico and in vitro experiments demonstrated that resveratrol binds to the active site of human CYP1A2 through hydrophobic interactions with PHE125, PHE226, PHE260, and ALA317, and hydrogen bonds with SER122 and ASP313. It inhibits human recombinant CYP1A2 activity as well as that in rat liver microsomes, with IC50 values of 46 µM and 485 µM, respectively. Resveratrol showed a mixed type of inhibition of recombinant human protein and a competitive inhibition of rat liver microsomal CYP1A. Conclusions: We can conclude that resveratrol is an in vitro inhibitor of CYP1A2, but it increases the benzo[a]pyrene CYP induction effect in vivo.

26 August 2026 in Foods
Verified
Journal Article
Open access
PDF file
KGKarla S. Garcia-Salazar
Karla S. Garcia-Salazar
RLRaquel Lopez-Arellano
Raquel Lopez-Arellano
JLJuan Latorre
Juan Latorre
EHElvia Adriana Morales Hipólito
Elvia Adriana Morales Hipólito
JMJorge L. Mejía-Méndez
Jorge L. Mejía-Méndez
DHDaniel Hernandez-Patlan
Daniel Hernandez-Patlan
Aflatoxin B1 (AFB1) contamination of feed used in poultry farming is an important issue in food safety since it compromises animal productivity and leads to the transfer of toxic waste to the food chain. In this sense, as an alternative to conventional mineral adsorbents, in the present study, two sustainable and low-cost biochars were obtained from agro-industrial waste of orange peel (B-OP) and guava leaves (B-GL) to evaluate their efficiency in the removal of AFB1 in an in vitro avian model. Biochars were obtained from pyrolysis and characterized in terms of particle size, surface area, morphology, surface charge, surface chemistry, and pore size. Furthermore, their adsorption capacity was evaluated in an avian in vitro model. The results showed that B-OP had a smaller particle size (55.30 µm), a larger specific surface area (31.50 m2/g), and a smaller pore size (2.38 nm) than B-GL (82.88 µm, 9.74 m2/g, and 6.24 nm). Furthermore, the biochars presented different morphologies, FTIR spectra, and zeta potentials. In the avian in vitro model, the feed matrix reduced the effectiveness of AFB1 removal compared to the in vitro model using only buffer solutions. However, B-OP (27.4%) significantly outperformed B-GL (22.7%) in the intestinal segment. The valorization of these agro-industrial wastes into biochar represents an economical and sustainable strategy for removing AFB1 and strengthening food security.